‘Osteoimmunology' Offers New Perspectives for the Treatment of Pathological Bone Loss
Journal:
Current Pharmaceutical Design
Volume:
23
Page:
6272-6278
Author(s):
Hongrui Liu, Tingting Luo, Jiali Tan, Minqi Li and Jie Guo*
Pivotal Roles of Interleukin-17 as the Epicenter of Bone Loss Diseases
Journal:
Current Pharmaceutical Design
Volume:
23
Page:
6302-6309
Author(s):
Chongshan Liao, Chengfei Zhang and Yanqi Yang*
New Strategies for the Prevention and Treatment of Systemic and Local Bone Loss; from Pathophysiology to Clinical Application
Journal:
Current Pharmaceutical Design
Volume:
23
Page:
6241-6250
Author(s):
Angelo Fassio*, Maurizio Rossini , Ombretta Viapiana, Luca Idolazzi, Elisabetta Vantaggiato, Camilla Benini and Davide Gatti
A Clinical Update and Global Economic Burden of Rheumatoid Arthritis
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
18
Page:
98-109
Author(s):
Syed Ali Fazal, Mohammad Khan, Shamima E. Nishi, Fahmida Alam, Nowshin Zarin, Mohammad T. Bari and Ghulam Md. Ashraf*
The Anti-Migraine Effects of M2000 (β-D-Mannuronic Acid) on a Patient with Rheumatoid Arthritis: Case Report
Journal:
Current Clinical Pharmacology
Volume:
12
Page:
127-130
Author(s):
Mahdi Vojdanian, Hossein Ahmadi, Ahmad Reza Jamshidi, Mahdi Mahmoudi, Farhad Gharibdoost, Anis Barati and Abbas Mirshafiey*
Phospholipid/Bile Salt Based Novel Mixed Nanomicelles of Methotrexate Co-encapsulated with Sesamol: Preparation, Characterization, and Evaluation of Antiradical Effects In Vitro
Journal:
Current Nanomedicine
Volume:
8
Page:
69-85
Author(s):
Jessy Shaji* and Dhanila Varkey
Gold - Old Drug with New Potentials
Journal:
Current Medicinal Chemistry
Volume:
25
Page:
75-84
Author(s):
Gavino Faa, Clara Gerosa, Daniela Fanni, Joanna I. Lachowicz and Valeria M. Nurchi*
IL-27: Friend or Foe in the Autoimmune Diseases
Journal:
Current Immunology Reviews (Discontinued)
Volume:
13
Page:
163-170
Author(s):
Mostafa Ejtehadifar, Sarah Zahedi, Ghasem Mosayebi, Ghasem Ghalamfarsa, Abbas Pishdadian, Ali Ghazavi, Mohsen Ebrahimi and Ali Ganji*
Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
13
Page:
86-105
Author(s):
Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*
α-Mangostin, A Natural Xanthone, Induces Apoptosis and ROS Accumulation in Human Rheumatoid Fibroblast-Like Synoviocyte MH7A Cells
Journal:
Current Molecular Medicine
Volume:
17
Page:
375-380
Author(s):
J. Zhang*, Q. Chen, S. Wang, T. Li, Z. Xiao, W. Lan, G. Huang and X. Cai*